Jerry S Wolinsky Selected Research

Human Influenza (Influenza)

11/2019

Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerry S Wolinsky Research Topics

Disease

48	Multiple Sclerosis 03/2024 - 05/2003
19	Relapsing-Remitting Multiple Sclerosis 04/2023 - 04/2004
13	Chronic Progressive Multiple Sclerosis 10/2021 - 06/2004
8	Infections 01/2021 - 03/2014
7	Disease Progression 12/2020 - 11/2011
4	Inflammation (Inflammations) 12/2019 - 04/2005
3	Atrophy 01/2020 - 04/2005
3	Respiratory Tract Infections (Respiratory Tract Infection) 11/2019 - 10/2014
2	Neoplasms (Cancer) 01/2017 - 01/2017
2	Fatigue 05/2016 - 05/2014
2	Headache (Headaches) 01/2016 - 03/2014
2	Nausea 01/2016 - 10/2011
2	Diarrhea 01/2016 - 10/2011
1	Tremor (Tremors) 10/2023
1	Genetic Risk Score 01/2023
1	Human Influenza (Influenza) 11/2019
1	Urinary Tract Infections (Urinary Tract Infection) 11/2019
1	Pruritus (Itching) 05/2019
1	Bronchial Spasm 05/2019
1	Exanthema (Rash) 05/2019
1	Flushing 05/2019
1	Supraventricular Tachycardia 01/2018
1	Leukopenia 01/2018
1	Seizures (Absence Seizure) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2016
1	Bradycardia 03/2016
1	Lymphopenia (Lymphocytopenia) 03/2016
1	Atrioventricular Block 03/2016
1	Herpes Zoster 01/2015
1	Cognitive Dysfunction 11/2010
1	Pathologic Processes 06/2002

Drug/Important Bio-Agent (IBA)

14	ocrelizumabIBA 01/2022 - 01/2017
14	teriflunomideIBA 11/2020 - 10/2011
13	Glatiramer Acetate (Copaxone)FDA Link 04/2023 - 08/2003
7	Interferon beta-1a FDA Link 04/2023 - 04/2014
6	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 01/2015
5	InterferonsIBA 01/2021 - 03/2013
5	GadoliniumIBA 01/2020 - 04/2005
5	Immunologic Factors (Immunomodulators)IBA 01/2018 - 09/2014
4	Biomarkers (Surrogate Marker)IBA 12/2019 - 06/2002
3	Alanine Transaminase (SGPT)IBA 01/2016 - 03/2014
2	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024 - 01/2019
2	evobrutinibIBA 03/2024 - 01/2019
2	Natalizumab (Tysabri)FDA Link 01/2021 - 09/2010
2	diroximel fumarateIBA 11/2020 - 01/2020
2	FumaratesIBA 11/2020 - 01/2020
2	Dimethyl FumarateIBA 01/2020 - 01/2019
2	Protons (Proton)IBA 02/2009 - 06/2004
2	Peptides (Polypeptides)IBA 01/2006 - 04/2004
1	25-hydroxyvitamin DIBA 01/2023
1	hydroxide ionIBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	Biotin (Vitamin H)FDA Link 12/2020
1	Contrast MediaIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	insulin receptor-related receptor (IRR)IBA 05/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	Sphingosine-1-Phosphate ReceptorsIBA 03/2016
1	Complement System Proteins (Complement)IBA 09/2013
1	Rituximab (Mabthera)FDA Link 05/2013
1	Interferon-betaIBA 11/2010

Therapy/Procedure

19	Therapeutics 04/2023 - 05/2003
1	Surgical Instruments (Clip) 10/2023
1	Subcutaneous Injections 07/2015
1	Oral Administration 03/2006